Table 1.

Characteristics of included transplant candidates at the time of initiation of a second-opinion evaluation at our center

Patient Characterstics	All	Not Waitlisted	Waitlisted	P Value
	n=53 (100%)	n=34 (64%)	n=19 (36%)
Age, yr	58 (45–68)	59 (52–68)	51 (27–68)	0.15
Female sex	22 (42)	13 (38)	9 (47)	0.52
Race/ethnicity				0.006
Black, non-Hispanic	12 (23)	5 (15)	7 (37)
Hispanic	4 (8)	3 (9)	1 (5)
White, non-Hispanic	25 (47)	14 (41)	11 (58)
Other	12 (23)	12 (35)	0 (0)
On dialysis at evaluation start	45 (85)	30 (88)	15 (79)	0.44
Diabetes	27 (51)	21 (62)	6 (32)	0.04
Coronary artery disease	4 (8)	4 (12)	0 (0)	0.37
Prior stroke or TIA	4 (8)	2 (6)	2 (11)	0.61
Heart failure	11 (21)	9 (26)	2 (11)	0.29
Peripheral vascular disease	9 (17)	7 (21)	2 (11)	0.46
Limb amputation	6 (11)	5 (15)	1 (5)	0.40
Employed	17 (32)	6 (18)	11 (58)	0.003
Declined by two prior centers	5 (9)	2 (6)	3 (16)
Prior evaluation center location
New York City or Long Island	26 (49)	16 (47)	10 (53)	0.73
New York State (not NYC)	5 (9)	4 (12)	1 (5)
Other state	22 (42)	14 (41)	8 (42)
Reason not listed at initial evaluationa				—
Cardiac disease	9 (17)	6 (18)	3 (16)
Vascular disease	7 (13)	5 (15)	2 (11)
Immunologic risk	4 (8)	2 (6)	2 (11)
Other medical risk	22 (42)	11 (32)	11 (58)
Alcohol or substance use	5 (9)	2 (6)	3 (16)
Nonadherence	5 (9)	4 (12)	1 (5)
Other psychosocial	3 (6)	2 (6)	1 (5)
Not documented	3 (6)	3 (9)	0 (0)
Completed evaluation	29 (55)	10 (29)	19 (100)	<0.001
Time to complete evaluation, wk	24 (13–41)	16 (3–30)	27 (16–46)	0.03
Received a transplant	—	—	14 (74)	—
Living donor transplant	—	—	10 (71)
Deceased donor transplant	—	—	4 (29)
1-yr patient and graft survival	—	—	14 (100)

NYC, New York City; TIA, transient ischemic attack.

^aColumns exceed 100% and no between-group tests performed because of multiple reasons listed for individual patients.